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Various attempts have been made to delineate "specific clinical features" that occur with DST nonsuppression. Carroll et al. (1976) and Schlesser et al. (1979) failed to find any manifestations that convincingly distinguished nonsuppressors from suppressors. Winokur et al. (1978) and Lewis and Winokur (1983) reported that nonsuppression was more frequently associated with distinct genetic subtypes of depression, but others have challenged this finding (Carroll et al. 1980; Rudorfer et al. 1982) . Reus (1982) suggested that nonsuppressors have more "classical endogenous signs of dysfunction" on admission, and more subjective complaints than suppressors. Nasr et al. (1983) also found that the DST discriminated between clinical subtypes.
A major problem in most prior reports is that associations between DST nonsuppression and endogeneity have been evaluated only in dichotomous subgroups, e.g., DST suppressors versus nonsuppressors or endogenous versus nonendogenous depressives. Unfortunately, considerable information is lost when categorical analyses constitute the sole approach; relationships between absolute hypothalamic-pituitary-adrenal (HPA) values and severity or degree of endogeneity may be missed.
To help clarify this somewhat controversial question, we examined the relationship between endogeneity and absolute postdexamethasone plasma cortisol levels. We hypothesized that as the absolute severity of the depressive syndrome and/or the number of endogenous symptoms increased, DST cortisol levels also would increase.
Methods

Subjects
Our sample consisted of 73 patients hospitalized in the Clinical Studies Unit (CSU) for Affective Disorders at the University of Michigan during 1979 Michigan during -1984 . Each individual was evaluated with the standard CSU protocol: (1) a IO-14-day drug washout period, (2) comprehensive medical and neurological examination, (3) differential, absolute blood counts, thyroid studies, B12 and folate levels, and VDRL, (4) electrocardiogram (EKG), electroencephalogram (EEG), chest and skull x-ray, (5) at least two independent, unstructured clinical evaluations by CSU psychiatrists, (6) a structured assessment by a trained interviewer using the Schedule for Affective Disorders and Schizophrenia (SADS) (Spitzer and Endicott 1975) , (7) a family interview whenever feasible to confirm family history and longitudinal course, and (8) a review of prior medical records if available. At completion of these data collections, a consensus diagnosis was formulated using Research Diagnostic Criteria (RDC) (Spitzer et al. 1977) . All patients were diagnosed as having major depressive disorder (MDD) using RDC. Clinical and demographic characteristics of the patient sample are shown in Table 1 .
Operational Dejinitions of Endogeneity
Because a primary objective was to determine if DST values reflected degree of endogeneity, it was essential to have close temporal linkage between DSTs and measures of endogeneity. To accomplish this, we selected the DST from the time period immediately prior to treatment (10-14 days drug-free), thus controlling for sources of variance due to treatment. SADS interviews were not always conducted at the exact time when the drug-free DST was performed, but the Hamilton Rating Scale for Depression (HRSD) and the CSU current status forms were completed on the same day. Thus, to determine the degree of endogeneity, we developed an o~rationa1 index of "endogeneity" to match the endogeneity items from the RDC. The comparisons are illustrated in Table 2 . The index was compiled using the Hamilton Rating Scale for Depression (Hamilton 1960) and the CSU Current Status form (this is a clinical questionnaire that clinicians on the unit complete on a weekly basis). Using this index, it was possible to compare postdexamethasone cortisof values and endogeneity at the same time point. We then divided subjects into three categories, based on the number of endogenous items they manifested, i.e., nonendogenous (O-3 items), probable endogenous (4-6 items), and definite endogenous (6 items and more). We thus developed measures of both categorical endogenous groups and actual degree of endogeneity (based on the number of endogenous symptoms). In compiling our "endogeneity" index and classifying patients into the three categories described above, we paid primary attention to the absolute number of endogenous symptoms. Groupings of symptoms (e.g., Group A versus Group B in RDC) were neither considered mandatory nor were they given any extra significance.
Clinical raters in the CSU always are blind to DST results.
We used our previously standardized approach for the DST (Carroll et al. 198 1) . All patients received 1 mg of oral dexamethasone at 11:OO PM, and plasma samples were collected the following day at 4:00 PM and 1 I:00 PM. Plasma cortisol concentrations were assayed using a modification of Murphy's competitive protein binding technique (Murphy, 1967) . Our intraassay coefficient of variance is 6.5% and interassay coefficient of variation is 9%. In the CSU, a cortisol value >5 pgidl is considered to be "nonsuppression." This cut-off value was established in our setting only after comparisons of endogenous depressives, psychiatric controls, and normal controls. In our studies, the maximum cortisol level from either the 4:00 PM or 11:OO PM samples was used as the indicator of HPA dysregulation. This value should not be adopted indiscriminately in other settings. To improve normality of distribution and equality of variance, we log-transformed plasma dexamethasone concentrations prior to any statistical analyses. To compare subgroups on categorical dimensions, we used the (x') test and the maximum likelihood estimate (MLE) (for tables larger than 7 x 2 with 0 cells). The one-way Analysis of Variance (ANOVA) was employed for analyses of differences among levels of endogeneity.
A one-way Analysis of Covariance model (ANCOVA), with weight and age as covariates. also was used.
Results
There was a statistically significant relationship (Y = 0.27.1~ = 0.02) between maximum postdexamethasone cortisol level and the degree of endogeneity (Figure 1) . Consistent with this correlation. when the three categorical endogenous subgroups (non, probable. and definite) were examined, the percentage of nonsuppressors increased with endogeneity from 0% for the nonendogenous to 52% for the probable endogenous, to 61% for the definite endogenous (Table 3 ). The mean of maximum cortisol in each of the three subgroups also increased with endogeneity (Table 3) . These observations establish a link between degree of endogeneity and postdexamethasone plasma levels. Thus, our hypothesis was supported. given the constraints placed on it by the small size (II = 4) 01 our nonendogenous group. When we evaluated severity relationships with DST values, we found that DST values were even more strongly correlated with severity of depression (as demonstrated by HRSD scores) (I' = 0.35. I) = 0.000) than they were with degree ofendogeneity (see Figure 2) . We then evaluated the associations between "endogeneity" as described in the RDC and total HRSD items and found a significant correlation (r = 0.68, p = 0.000). Thus, endogeneity per se is highly confounded with severity of depression. Indeed, the items on the HRSD that we did not consider to be conventionally "endogenous" also correlated significantly with postdexamethasone cortisol levels (r = 0.49, p = 0.000).
NUMBER OF ENDOGENOUS SYMPTOMS
The two endogenous and the nonendogenous subgroups did not differ significantly in terms of gender distribution, proportion of unipolar to bipolar, number of previous episodes, or presence of delusions (Table 1) .
Age and weight loss have been reported to confound the relationship between DST and severity. One-way ANOVA revealed that patients who were definitely endogenous were older and reported greater weight loss (HRSD item 17) in this episode (Table 1) . However, a one-way ANCOVA model, testing for the effect of group membership (endogeneity) on DST and treating age and weight loss as covariates, showed that this effect was not influenced by the covariates. When absolute weight was a covariate, however, we found that although a significant relationship existed between DST and this covariate (F = 11.96, p < O.OOl), group membership continued to have a significant effect in the prediction of DST (F = 4.49, p = 0.01). Thus, endogeneity remained a significant predictor of DST when absolute weight was held constant. The number of subjects in each category is in parentheses.
Discussion
These data indicate that postdexamethasone plasma cortisol concentrations moderateI> reflect the degree of endogeneity.
regardless of whether endogeneity is considered J continuous or a dichotomous variable. However, this correlation is not specific for "endogeneity" per se; DST values appear to reflect total severity of depression (HRSD total I even more strongly than endogeneity.
This relationship between severity of depression and the DST has received only sporadic attention. and most reports dealing with this question have considered DST results categorically, i.e.. suppressors versus nonsuppressors. Carroll et al. ( 1968) initially reported an association between severity of depression and resistance to dexamethasone suppression. but in later reports Carroll and colleagues failed to contirm this relationship (Carroll and Davis 1970. Carroll et al. 1981) . Brown et al. (1979) and Stokes et al. i 1975) found that DST nonsuppressors were more severely depressed than suppressors. Davis et al ( I981 ) also noted that HRSD severity scores correlated positively and significantly with postdexamethasone cortisol concentrations; in contrast, predexamethasone baseline cortisol levels did not correlate with severity of depression. Brown and Shuey ( 1980) sug gested that nonsuppressors have greater cognitive impairment than suppressors, based on their inability to complete self-rating forms. but these authors felt that suppressors and nonsuppressors did not differ significantly in severity of depression as measured by HRSD scores. Brown and Qualls ( IO8 I ) also contended that nonsuppressors and suppressors did not differ in either severity or symptomatology.
Thus, there are conflicting viewpoint\ concerning this issue when DST values are considered only categorically Few studies have analyzed DST cortisol levels on a continuum, such as described 111 this report. Reus (1982) showed that patients with high levels of predexamethasone 8:(H) AM cortisol were more symptomatic on admission than those with normal levels, partic ularly in areas of anxiety and somatic concerns. Starkman and Schteingart ( 1981) studied patients with Cushing's syndrome and observed a statistically significant relationship between the overall neuropsychiatric disability score and the degree of cortisol elevation whether measured by cortisol secretion rate. urinary free cortisol. or plasma cortisol. at X:00 AM. They also suggested that the relative proportion of cortisol to adrencorticotrophin hormone (ACTH), rather than the level of either hormone itself. seemed to be related most closely to severity of "depressed mood." Feinberg and Carroll (1984i agreed that the 4:(H) PM sample of plasma cortisol correlated significantly with HRSD scores. Thus. there is a growing concensus that absolute DST values do reflect severity of depression Recent weight loss has been suggested to alter hypothalamic-pituitary-adrenal functiort (Berger et al. 1982; Edelstein et al. 1983 ). Feinberg and Carroll (1984) demonstrated that weight loss is highly confounded with total severity and age. This is predictable, 01 course, because weight and appetite changes are integral components of major depression. Our data suggest that absolute weight may be as important a predictor of DST as reported weight loss per se, perhaps because the latter is so unreliable.
In addition to confirming previously reported relationships between DST values and endogeneity , these data dramatize several aspects of endogeneity First, it may be essential to consider endogeneity on a continuum, as well as categorically. Although clinicianx are inclined to consider many clinical concepts as "present" or "not present," "end{) geneity" more accurately may reflect a continuous degree of limbic pathophysiology. manifesting itself in increasing disturbances of reward reinforcement (anhedonia; loss (1% reactivity). sleep (initial. middle. or late insomnia; hypersomnia). psychomotor agitaticlrl 1986;21:436-444 or ret~dation; loss of, decreases in, or increases in libido, appetite (and thus weight changes), and chronobiological dysrythmias (diurnal mood variation). The DST, which is also regulated by the same limbic-hypothalamic regulatory regions, appears to parallel this severity of endogenous/limbic dysregulation.
Our data also confirm that endogeneity is confounded with total severity of depression.
Even clinical items not ~aditionally considered to be "endogenous" are correlated with endogeneity. Caution is required in inte~reting some of our data, given the small population of the nonendogenous group. These data suggest that considerable information is lost when clinical profiles are only considered dichotomously.
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